Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Broadlight a provider of highly integrated networking and fiber access PON (Passive Optical Network) processors in its acquisition by Broadcom Corporation a global leader in semiconductor solutions for wired and wireless communications for approximately $220 million. The transaction was completed on April 5, 2012.
Meitar represented Anobit Israeli semiconductor startup in its acquisition by a multinational corporation.
Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of Face.com, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.
Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.
Meitar represented Fundtech Ltd., a leading provider of software and services to banks of all sizes around the world in its acquisition by GTCR, a leading private equity firm, for approximately $390 million. The merger agreement was signed after Fundtech terminated its merger agreement with S1 Corporation.
Meitar represented Gazit-Globe (TASE: GLOB; NYSE: GZT), one of the largest owners and operators of supermarket-anchored shopping centers in the world, in its initial public offering in the New York Stock Exchange.
